Ep191: Emily Conley on Small Molecules to Correct a Rare Kidney Disease
The Long Run with Luke Timmerman
00:00
Intro
Luke introduces Emily Conley and Renaissance Bio's mission to develop small molecules for ADPKD.
Play episode from 00:00
Transcript
